Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 12/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RHEB | Q15382 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7877811 | 0.99 | HRH3 (0.41) | HRH3KDM4EMAPTGAAKDR | |
| SCHEMBL7884245 | 0.91 | FAAH (0.40) | KDM4EGAAPARP1 | |
| SCHEMBL7881368 | 0.91 | KDM4E (0.39) | KDM4EGAAPARP1 | |
| SCHEMBL7877879 | 0.89 | DYRK1A (0.36) | HRH3DRD2DRD3PARP1 | |
| SCHEMBL7881038 | 0.88 | SCN9A (0.40) | HRH3KDM4EMAPTRHEBKDR | |
| SCHEMBL7880055 | 0.88 | CHEK1 (0.34) | HRH3DRD2DRD3PARP1 | |
| SCHEMBL7882167 | 0.87 | SCN9A (0.39) | HRH3KDM4EMAPTRHEBKDR | |
| SCHEMBL7879405 | 0.87 | ST14 (0.41) | RHEBDRD2DRD3 | |
| SCHEMBL7881919 | 0.87 | KDR (0.34) | HRH3RHEBDRD2DRD3KDR | |
| SCHEMBL7880873 | 0.86 | RXFP1 (0.43) | HRH3KDM4EMAPTDRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248772-B1 | HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6169107-B1 | USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS | SUMITOMO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0708091-A2 | Indoloylguanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |